VR
Viridian Therapeutics, Inc.
VRDN · NASDAQ
$21.24 -5.31% (-$1.19)
1M -2.58%
Market Cap $2.53B
P/E Ratio -
Div. Yield -
ROE 61.35%
Bulios Fair Price
$30.41
43.2% upside
Trenutna cena
$21.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VRDN trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
27 /100
Expensive P/S 35.50x
P/B 3.81x
P/E N/A
Growth
100 /100
Growing Rev. growth 241.95%
Book val. growth 22.27%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 99.38%
Net margin 544.06%
FCF margin 471.04%
Quality
1 /100
Poor ROIC 39.18%
ROE 61.35%
Asset turnover 0.06x
Debt
66 /100
Moderate Debt/Equity 0.37x
Current ratio 16.95x
Int. coverage -19.77x
Stability
42 /100
Moderate Beta 0.96x
Rev. volatility 13,511.78%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VRDN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen F. Mahoney
Employees
252
Headquarters
Waltham
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report